ScholarWorks@Korea University: Kim, Ae ree

Detailed Information

Kim, Ae ree (김애리)

Department of Biomedical Sciences

Research Area

Tel 구3253
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Breast cancer:7||breast cancer:5||Metaanalysis:4||Adenocarcinoma:4||prognosis:3||Breast neoplasms:3||Bmi1:3||Lung:3||HER3:2||Metastatic breast cancer:2||Immunohistochemistry:2||Perivascular epithelioid cell neoplasms:2||Metformin:2||immunohistochemistry:2||Heregulin:2||Human papillomavirus:2||ErbB3:2||epithelialmesenchymal transition:2||Carcinoma:2||Prognosis:2||moesin:2||Nanog:2||Breast:2||EMT:2||neural stem cells:2||RNA:2||tumorinfiltrating lymphocytes:2||estrogen receptor:1||programmed cell death ligand1:1||malignant salivary gland tumors:1||PDL1:1||small interfering RNA (siRNA):1||S100 proteins:1||Lung neoplasms:1||Tamoxifen resistance:1||Bohai:1||PI3K/AKT:1||2dimensional electrophoresis:1||mass spectrometry:1||SIRT1:1||Neoplasm metastasis:1||Proteomics:1||tissue array analysis:1||reprogramming:1||transdifferentiation:1||Anthracyclines:1||Taxanes:1||Bevacizumab:1||Lower lip:1||Okadaic acid:1||Resistin:1||Placenta:1||synchrotron:1||Dermatofibroma:1||Eccrine porocarcinoma:1||insulin receptor substrate 1:1||Estrogens:1||Smad2/3:1||tumor progression:1||tamoxifen resistance:1||liquidbased cytology:1||adenocarcinoma:1||Small interfering RNA (siRNA):1||CD8(+) T cell:1||cytokeratin 17:1||PROTEINS:1||Gastric cancer:1||Cervista HPV HR:1||Seeplex HPV4A ACE:1||Twin births:1||Salvage treatment:1||Phosphatase and tensin homolog deleted on chromosome ten:1||Immunoglobulin g:1||Plasma cell granuloma:1||Factor analysis:1||Tissue banks:1||Biological specimen bank:1||Peroxisome proliferating response elememt:1||atherosclerosis:1||Squamous cell carcinomain situ:1||Sequence analysis:1||CTLA4:1||East Asia:1||invasion:1||resistance:1||Prognostic marker:1||TGFbeta/SMAD2:1||amniotic fluidderived mesenchymal stem cells (AFMSCs):1||Ki67 antigen:1||Foxp3(+) Treg:1||microRNA:1||SIRT1 protein, human:1||methylation:1||carcinoma:1||fibroblasts:1||p53(/) Astrocytes:1||Vinorelbine:1||Pheochromocytoma:1||Adrenal glands:1||Ultrasonography:1||Tomography:1||plaque:1||basal:1||breast carcinoma:1||insulin resistance:1||Akt:1||massively parallel sequencing:1||Malignant eccrine poroma:1||s disease:1||hepatocellular carcinoma:1||programmed cell death protein 1:1||suryongs:1||Reprogramming:1||erbB3:1||receptor tyrosine kinase:1||cell signaling:1||YKL40:1||hypoxia:1||wound healing:1||ThinPrep:1||DNA:1||quality:1||HSP70 heatshock proteins:1||advanced gastric carcinoma:1||Colon:1||DBC1:1||docetaxel:1||BRAF:1||Cervista HPV 16/18:1||Ovary:1||Mammalian target of rapamycin:1||Composite pheochromocytoma and ganglioneuroma:1||Paraganglioma:1||Selfrenewal:1||Protein phosphatase 2A:1||Pathology:1||Bioethics:1||Preeclampsia:1||unmonochromatized:1||dedifferentiation:1||peroxisome proliferatoractivated receptors:1||tumor necrosis factor:1||Cutaneous horn:1||Hepatocellular carcinoma:1||renal cell:1||Granulomatous reaction:1||Immunihistochemistry:1||Homerin protein:1||Solitary pulmonary nodule:1||cancer stem cell:1||Induced pluripotent stem cell (iPSC):1||cancer:1||Transforming growth factorbeta (TGFbeta):1||iPSCs:1||thyroid:1||proteomics:1||DBC1 protein, human:1||insulin:1||HPV 16:1||Melanoma:1||Teratoma:1||induced pluripotent stem cells:1||Oct4:1||VEGF:1||Epidermal growth factor receptor:1||Autoimmune pancreatitis:1||Regression analysis:1||Law enforcement:1||ELISA:1||Translation:1||survival:1||relapsefree survival:1||history:1||neuregulin:1||migration:1||Sonic hedgehog:1||Liquidbased preparation:1||colorectal carcinoma:1||Polycomb group proteins:1||BMI1 (B lymphoma MoMLV insertion region 1 homolog):1||cyclin B1:1||breast:1||endoderm:1||HPV 18:1||Tumorigenicity:1||936 C/T polymorphism:1||Angiomyoma:1||Xenofree:1||Korean bioethics:1||Large Cell Neuroendocrine Carcinoma:1||apo Eknockout mouse:1||astrocytes:1||Genetic heterogeneity:1||ductal carcinoma in situ:1||Porocarcinoma:1||alphahuman papillomavirus:1||epidermal growth factor (EGF):1||Uterus:1||HRGbeta 1:1||Far East:1||CD44:1||Early gastric carcinoma:1||early breast cancer:1||FNA:1||triplenegative:1||dermis:1||mesenchymal stem cells:1||Liquidbased preparation of cytology specimens:1||Papillary carcinoma:1||Brain cancer stem celllike cells:1||Breast cancer risk:1||Pulmonary:1||Human embryonic stem cells:1||Ductal:1||XRay Computed:1||nonalcoholic fatty liver:1||Matrix metalloproteinase9:1||Bowen&apos:1||Nextgeneration sequencing:1||Receptors:1||cytotoxic T lymphocyteassociated molecule4:1||Kidney neoplasms:1||PDL2:1||Realtime polymerase chain reaction:1||Receptor tyrosine kinase HER2:1||metaanalysis:1||periphery:1||intrinsic subtype:1||MMP9:1||Small molecule compounds:1||stomach:1||Smad2:1||Beta catenin:1||Stomach:1||EZH2 (enhancer of zeste homologue 2):1||DNMT3B (DNA methyltransferase 3B):1||RASSF1A:1||cell differentiation:1||humans:1||Thyroid:1||Highrisk HPV:1||Dedifferentiation:1||Chemotherapy:1||Human biorepository network:1||neural stem celllike cells:1||gene expression profile:1||MAPK:1||

STATISTICS: Total View :6,941,794; Today View :7,867

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE